These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 24287555)

  • 1. Palladium-103 plaque radiation therapy for American Joint Committee on cancer T3- and T4-staged choroidal melanomas.
    Semenova E; Finger PT
    JAMA Ophthalmol; 2014 Feb; 132(2):205-13. PubMed ID: 24287555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palladium-103 radiation therapy for small choroidal melanoma.
    Semenova E; Finger PT
    Ophthalmology; 2013 Nov; 120(11):2353-7. PubMed ID: 23774104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve.
    Finger PT; Chin KJ; Tena LB
    Ophthalmology; 2012 Feb; 119(2):415-22. PubMed ID: 22133796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients.
    Finger PT; Chin KJ; Duvall G;
    Ophthalmology; 2009 Apr; 116(4):790-6, 796.e1. PubMed ID: 19243829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study.
    Finger PT; Berson A; Szechter A
    Ophthalmology; 1999 Mar; 106(3):606-13. PubMed ID: 10080222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of choroidal melanomas treated with eye physics: a 20-year review.
    Berry JL; Dandapani SV; Stevanovic M; Lee TC; Astrahan M; Murphree AL; Kim JW
    JAMA Ophthalmol; 2013 Nov; 131(11):1435-42. PubMed ID: 24008431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 12-Year Study of Slotted Palladium-103 Plaque Radiation Therapy for Choroidal Melanoma: Near, Touching, or Surrounding the Optic Nerve.
    Maheshwari A; Finger PT
    Am J Ophthalmol; 2018 Apr; 188():60-69. PubMed ID: 29409899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subfoveal choroidal melanoma: pretreatment characteristics and response to plaque radiation therapy.
    Newman H; Chin KJ; Finger PT
    Arch Ophthalmol; 2011 Jul; 129(7):892-8. PubMed ID: 21746980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases.
    Sagoo MS; Shields CL; Emrich J; Mashayekhi A; Komarnicky L; Shields JA
    JAMA Ophthalmol; 2014 Jun; 132(6):697-702. PubMed ID: 24652552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for radiation maculopathy after ophthalmic plaque radiation for choroidal melanoma.
    Finger PT; Chin KJ; Yu GP;
    Am J Ophthalmol; 2010 Apr; 149(4):608-15. PubMed ID: 20138602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of radiation maculopathy after palladium-103 plaque radiotherapy for iris melanoma.
    Yousef YA; Finger PT
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1107-12. PubMed ID: 22172910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy.
    Finger PT; Chin KJ
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):137-42. PubMed ID: 20395070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plaque radiotherapy for juxtapapillary choroidal melanoma overhanging the optic disc in 141 consecutive patients.
    Sagoo MS; Shields CL; Mashayekhi A; Freire J; Emrich J; Reiff J; Komarnicky L; Shields JA
    Arch Ophthalmol; 2008 Nov; 126(11):1515-22. PubMed ID: 19001218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual acuity, oncologic, and toxicity outcomes with
    Patel KR; Prabhu RS; Switchenko JM; Chowdhary M; Craven C; Mendoza P; Danish H; Grossniklaus HE; Aaberg TM; Aaberg T; Reddy S; Butker E; Bergstrom C; Crocker IR
    Brachytherapy; 2017; 16(3):646-653. PubMed ID: 28262517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma.
    Marconi DG; de Castro DG; Rebouças LM; Bernardes Gil GO; Fogaroli RC; Conte Maia MA; Gobo Silva ML; Assis Pellizzon AC; Motono Chojniak MM
    Brachytherapy; 2013; 12(3):235-9. PubMed ID: 22436517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of choroidal melanomas less than 10 mm in largest basal diameter with a 10-mm ruthenium plaque.
    Salkola S; Heikkonen J; Eskelin S; Kivelä T
    Retina; 2014 Oct; 34(10):2110-20. PubMed ID: 24978431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.
    Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plaque radiotherapy for choroidal melanoma encircling the optic disc (circumpapillary choroidal melanoma).
    Sagoo MS; Shields CL; Mashayekhi A; Freire J; Emrich J; Reiff J; Komarnicky L; Shields JA
    Arch Ophthalmol; 2007 Sep; 125(9):1202-9. PubMed ID: 17846359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study.
    Sobrin L; Schiffman JC; Markoe AM; Murray TG
    Ophthalmology; 2005 Oct; 112(10):1777-83. PubMed ID: 16095708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
    Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
    Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.